Document Type
Article
Publication Date
8-2022
Keywords
stroke; plasmin; blood clots; dissolution; degradation
Abstract
Strokes are among the leading causes of death worldwide. Ischemic stroke, due to plaque or other buildup blocking blood flow to the brain, is the most common type. Although ischemic stroke is treatable, current methods have severe shortcomings with high mortality rates. Clot retrieval devices, for example, can result in physically damaged vessels and death. This study aims to create blood clots that are representative of those found in vivo and demonstrate a new method of removing them. Static blood clots were formed using a 9:1 ratio of whole sheep blood and 2.45% calcium chloride solution. This mixture was heated in a water bath at 37 degrees C for approximately one hour until solidified. Following clot solidification, human plasmin was introduced by various methods, including soaking, injection, and membrane perfusion, and the resulting dissolution percentages were determined. Different clot types, representative of the wide range found physiologically, were also manufactured and their dissolution characteristics evaluated. A method to reproducibly create blood clots, characteristic of those found in vivo, is essential for the production of stroke retrieval devices that can efficiently and effectively remove clots from patients with low mortality rates and little/no damage to the surrounding vessels.
Citation
Wood, K., Stephens, S. E., Xu, F., Hazaa, A., Meek, J. C., Jensen, H. K., Jensen, M. O., & Wickramasinghe, S. (2022). In Vitro Blood Clot Formation and Dissolution for Testing New Stroke-Treatment Devices. Biomedicines, 10 (8), 1870. https://doi.org/10.3390/bioengineering9040155
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
